Acute disseminated encephalomyelitis

Postgraduate Medical Journal

Volumn 79, Issue 927, 2003, Pages 11-17

  Garg, R K ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYELIN BASIC PROTEIN;

ACUTE DISEASE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; ENCEPHALOMYELITIS; FOLLOW UP; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PLASMAPHERESIS; PROGNOSIS; REVIEW; T LYMPHOCYTE;

ADULT; CHILD; DIAGNOSIS, DIFFERENTIAL; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; HUMANS; MAGNETIC RESONANCE IMAGING; PROGNOSIS;

EID: 0037281051     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.79.927.11     Document Type: Review

References (58)

1. Murthy SNK, Faden HS, Cohen ME, et al. Acute disseminated encephalomyelitis in children. Pediatrics 2002;110(2) (http;//www.pediatrics.org/cgi/content/full/110/2/e21).
2. Murthy JM, Yangala R, Meena AK, et al. Acute disseminated encephalomyelitis: clinical and MRI study from South India. J Neuro Sci 1999;165:133-8.
3. Litvak AM, Sands IJ, Gibel H. Encephalitis complicating measles: report of 56 cases with follow-up studies in 32. Am J Dis Child 1943;65:265-95.
4. Miller HG, Evans MJ. Prognosis in acute disseminated encephalomyelitis: with a note of neuromyelitis optica. Q J Med 1953;22:247-79.
5. Stuve O, Zamvil SS. Pathogenesis, diagnosis and treatment of acute disseminated encephalomyelitis. Curr Opin Neurology 1999;12:395-401.
6. Held JR, Adros HL. Neurological disease in man following administration of suckling mouse brain antirabies vaccine. Bull World Health Organ 1972;46:321-7.
7. Label LS, Batts DH. Transverse myelitis caused by duck embryo rabies vaccine. Arch Neurol 1982;39:426-30.
8. Swamy HS, Shankar SK, Satish Chandra P, et al. Neurological complications due to beta-propiolactone (BPL) inactivated antirabies vaccination. J Neurol Sci 1984;63:111-28.
9. Hemchudha T, Griffin DE, Giffels JJ, et al. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N Engl J Med 1987;316:369-74.
10. Murthy JMK. MRI in acute disseminated encephalomyelitis following Semple antirabies vaccine. Neuroradiology 1998;40:420-3.
11. Chakrawarty A. Neurologic illness following post-exposure prophylaxis with purified chick embryo cell antirabies vaccine. J Assoc Physicians India 2001;44:927-8.
12. Fenichel GM. Neurological complications of immunization. Ann Neurol 1982;12:119-28.
13. Nalin DR. Mumps, measles and rubella vaccination and encephalitis (letter). BMJ 1989;299:1219.
14. van Bogaert L. Post-infectious encephalomyelitis and multiple sclerosis: the significance of perivenous encephalomyelitis. J Neuropathol Exp Neurol 1950;9:219-49.
15. Allen IV. Demyelinating diseases. Greenfield's neuropathology. 4th Ed. In: Adams JH, Corsellis JAN, Duchen LW, eds. London: Edward Arnold, 1984:338-84.
16. Davies JM. Molecular mimicry: can epitope mimicry induce autoimmune disease? Immunol Cell Biol 1997;75:113-26.
17. Johnson RT. Pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis. J Infect Dis 1987;155:359-64.
18. Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990;8:579-621.
19. Gold R, Hartung HP, Toyka KV. Animal models for autoimmune demyelinating disorder of the nervous system. Mol Med Today 2000;62:88-91.
20. Laouini D, Kennou MF, Khoufi S, et al. Antibodies to human myelin proteins and gangliosides in patients with acute neuroparalytic accident induced by brain-derived rabies vaccine. J Neuroimmunol 1998;91:63-72.
21. 't Hart BA, Brok HP, Amor S, et al. The major histocompatibility complex influences the ethiopathogenesis of MS-like disease in primates at multiple levels. Hum Immunol 2001;62:1371-81.
22. Scully RE, Mark EJ, McNeely WF, et al. Case records of the Massachusetts General Hospital, case 37-1995. N Engl J Med 1995;333:1485-92.
23. Scully RE, Mark EJ, McNeely WF, et al. Case records of the Massachusetts General Hospital, case 1-1999. N Engl J Med 1999;340:127-35.
24. Stefansson K, Hedley-Whyte ET. Case records of the Massachusetts General Hospital, case 8-1996 - a 28 years old woman with rapid development of a major personality change and global aphasia. N Engl J Med 1996;334:715-21.
25. Liu J, Marino MW, Wong G, et al. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 1998;4:78-83.
26. Sabelko-Downes KA, Russell JH, Cross AH. Role of Fas-FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease. J Neuroimmunol 1999;100:42-52.
27. Boullerne AI, Nedelkoska L, Benjamins JA. Role of calcium in nitric oxide-induced cytotoxicity: EGTA protects mouse oligodendrocytes. J Neurosci Res 2001;63:124-35.
28. van der Goes A, Brouwer J, Hoekstra K, et al. Reactive oxygen species are required for the phagocytosis of myelin by macrophages. J Neuroimmunol 1998;92:67-75.
29. Matute C, Alberdi E, Domercq M, et al. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci 2001;24:224-30.
30. Murthy JMK, Yangala R, Meena AK, et al. Clinical, electrophysiological and magnetic resononce imaging study of acute disseminated encephalomyelitis. J Assoc Physicians India 1999;47:280-3.
31. Schwarz S, Mohr A, Knauth M, et al. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 2001;56:1313-18.
32. Apak RA, Kose G, Anlar B, et al. Acute disseminated encephalomyelitis in childhood: report of 10 cases. J Child Neurol 1999;14:198-201.
33. Dale RC, de Sousa C, Chong WK, et al. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123:2407-22.
34. Hynson JL, Kornberg AJ, Coleman LT, et al. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001;56:1308-12.
35. Hollinger P, Sturzenegger M, Mathis J, et al. Acute disseminated encephalomyelitis in adults: a reappraisal of clinical CSF, EEG and MRI findings. J Neurol 2002;249:320-9.
36. Lukes SA, Norman D. Computed tomography in acute disseminated encephalomyelitis. Ann Neurol 1983;13:567-72.
37. Caldmeyer KS, Smith RR, Harris TM, et al. MRI in acute disseminated encephalomyelitis. Neuroradiology 1994;36:216-20.
38. Singh S, Alexander M, Korah IP. Acute disseminated encephalomyelitis: MR imaging features. AJR Am J Roentgenol 1999;173:1101-7.
39. O'Riordan JI, Gomez-Anson B, Moseley IF, et al. Long term MRI Follow-up of patients with post-infectious encephalomyelitis: evidence for a monophasic disease. J Neurol Sci 1999;167:132-6.
40. Bizzi A, Ulug AM, Crawford TO, et al. Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 2001;22:1125-30.
41. Honkaniemi J, Dastidar P, Kahara V, et al. Delayed MR imaging changes in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 2001;22:1117-24.
42. Hartung HP, Grossman RI. ADEM: distinct disease or part of MS spectrum? Neurology 2001;56:1257-60.
43. Singh S, Prabhakar S, Korah IP, et al. Acute disseminated encephalomyelitis and multiple sclerosis: magnetic resonance imaging differentiation. Australas Radiol 2000;44:404-11.
44. Barkhof F, Filippi M, Miller DH, et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059-69.
45. Hung KL, Liao HT, Tsai ML. Post-infectious encephalomyelitis: etiologic and diagnostic trends. J Child Neurol 2000;15:666-70.
46. Cuadrado MJ, Khamashta MA, Ballesteros A, et al. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Medicine 2000;79:57-68.
47. Dey KB, Trikha I, Banerjee M, et al. Acute disseminated encephalomyelitis - another cause of postmalaria cerebeller ataxia. J Assoc Physicians India 2001;49:756-8.
48. Mohsen AH, Mckendrick MW, Schmid ML, et al. Postmalaria neurological syndrome: a case of disseminated encephalomyelitis. J Neurol Neurosurg Psychiatry 2000;68:388-90.
49. Straub J, Chofflon M, Delavelle J. Early high-dose intravenous methyl prednisolone in acute disseminated encephalomyelitis: a successful recovery. Neurology 1997;49:1145-7.
50. Kanter DS, Horensky D, Sperling RA, et al. Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology 1995;45:824-7.
51. Pradhan S, Gupta RP, Shashank S, et al. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci 1999;165:56-61.
52. Sahlas DJ, Miller SP, Guerin M, et al. Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 2000;54:1370-2.
53. Marchioni E, Marinou-Aktipi K, Uggetti C, et al. Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol 2002;249:100-4.
54. Keegan M, Pineda AA, McClelland RL, et al. Plasma exchange For severe attacks of CNS demyelination: predictors of response. Neurology 2002;58:143-6.
55. Cohen O, Steiner-Birmanns B, Biran I, et al. Recurrence of acute disseminated encephalomyelitis at the previously affected brain site. Arch Neurol 2001;38:797-801.
56. Belopitova L, Guergueltecheva PV, Bojinova V. Definite and suspected multiple sclerosis in children: long term follow-up and magnetic resonance imaging findings. J Child Neurol 2001;16:317-24.
57. Chou HVV, Hien TT, Sellar R, et al. "Can't you use another vaccine"? Post-rabies vaccination encephalitis [letter]. J Neurol Neurosurg Psychiatry 1999;67:555-6.
58. Modi G, Mochan A, Modi M, et al. Demyelinating disorder of the central nervous system occurring in black South Africans. J Neurol Neurosurg Psychiatry 2001;70:500-5.